The commercial space sector has crossed into recurring commercial revenue at scale. SpaceX’s Starlink unit is now throwing off subscription cash flow at a scale that supports an IPO pipeline being shepherded by Bank of America as lead underwriter. Pure-play satellite operators are booking recurring service revenue rather than one-off launch fees. Even prime defense contractors are calling out commercial space as a growth segment of its own: Lockheed Martin’s space business grew 7% in the most recent quarter as orbital demand stacked on top of geopolitical orders.
For investors who want to ride that transition without picking individual winners, three exchange-traded funds cover the territory with very different philosophies: SPDR S&P Kensho Final Frontiers ETF (NYSEARCA:ROKT), the brand new Roundhill MARS Space & Technology ETF (CBOE:MARS), and the ARK Space Exploration & Innovation ETF (NYSEARCA:ARKX). Each one captures the theme through a different lens, and the right pick depends on whether you want defense-anchored diversification, pure-play concentration, or active stock selection.
Why 2026 is the threshold year
Through 2024 the public space industry was still dominated by cost-plus government work and pre-revenue SPAC casualties. The story flipped over the last twelve months. Rocket Lab is launching at cadence, AST SpaceMobile is signing carrier deals on its direct-to-cell constellation, and Intuitive Machines has put two landers on the lunar surface under NASA’s commercial program rather than as a traditional contractor. The pending SpaceX listing would put a private valuation reported in the hundreds of billions onto public screens, and that single event will reset how every asset allocator treats space as an investable theme.
The structural shift matters because it changes what these ETFs actually own. Funds built three years ago held a basket of hope. The same funds today hold a basket of companies with rising commercial bookings and visible unit economics.
ROKT: the broad-mandate workhorse
State Street’s Final Frontiers fund is the oldest and largest way to play the theme, with an inception date of October 22, 2018 and a net expense ratio of 45 basis points. The investment logic here is balance. The S&P Kensho index methodology uses natural-language processing to flag companies whose products touch the “final frontier,” which Kensho defines to include both outer space and deep-sea exploration. That sounds like a stretch, until you notice the result: a portfolio with 54% aerospace and defense weight sitting alongside satellite imagery, lunar services, and subsea infrastructure.
What this means in practice is that ROKT pairs speculative pure-plays with cash-generating primes. The top holding is Planet Labs at 6%, followed by Intuitive Machines at about 5% and Iridium Communications at about 4%. Lockheed Martin, Northrop Grumman, and L3Harris sit in the middle of the book and provide a buffer when the small-cap space names get punished. The fund pays a modest 0.8% dividend, which is unusual for a frontier-tech ETF and reflects the defense exposure.
Performance has rewarded the patient. ROKT is up about 42% year to date and has more than doubled over the past year. The tradeoff is mandate creep. If you want exposure to satellites and launch, you are also paying for oilfield service names like Oceaneering, which carries a roughly 4% weight as the deep-sea proxy. Investors who want concentrated space exposure should look elsewhere.
MARS: the pure-play concentration bet
Roundhill launched MARS on March 5, 2026, and it is the cleanest expression of the commercial space thesis on the market. The fund is actively managed across what Roundhill calls the space value chain: launch, satellites, and space-enabled data services. Sector exposure breaks roughly into 51% industrials and 43% communication services, which is closer to what most investors picture when they hear “space ETF.”
The top of the book is where MARS earns its spot on this list. Rocket Lab sits at about 12%, EchoStar at about 11%, and AST SpaceMobile at about 10%, with those three names accounting for roughly a third of the portfolio. That is concentration most index products will not offer you. The fund also reaches into international names that ROKT misses entirely, with 8% allocated to Japan and 5% to Germany via OHB SE and SKY Perfect JSAT.
The numbers behind MARS demand caution. Total net assets sit at roughly $11.7 million, and the fund has only existed for a few months, which means bid-ask spreads can be wider than what you get with established products. The expense ratio of 75 basis points is the price of active management in a niche category. Since inception the fund is up roughly 57%, with an 18% gain in the last month alone. The tradeoff with this kind of concentration is symmetric: a Rocket Lab launch failure or an AST SpaceMobile delay would hit the fund hard.
ARKX: Cathie Wood’s high-conviction space book
ARK’s space fund is the contrarian inclusion on this list. ARKX spent its first three years as a punching bag for critics of thematic investing, and founder Cathie Wood’s strategy of buying speculative names with limited revenue at launch did look wrong in 2022 and 2023. The story has changed. ARKX is up about 20% year to date and has gained roughly 67% over the past twelve months as the holdings caught up to the thesis.
The investment logic for ARKX is different from the other two. ARK’s analysts are actively making bets on enabling technologies that may never appear in a standard space index: 3D printing for launch vehicles, AI-driven space situational awareness, and orbital robotics. Some of those bets will fail. The ones that work tend to compound aggressively because ARK builds positions before consensus catches up. If you already own ROKT or MARS, ARKX is the way to add exposure to companies that index methodologies will not capture for another year or two.
Picking the right tool
For most investors building a core space allocation, ROKT is the sensible default. It is the cheapest, the largest, and the most diversified, and the defense exposure cushions the bumps that always come with frontier sectors. Investors who already have aerospace exposure through a broad industrials or defense fund get little incremental diversification from ROKT, while MARS offers pure-play concentration they likely do not have elsewhere. ARKX belongs in the satellite position of a portfolio: a smaller weight alongside one of the other two, owned for the chance that ARK’s research picks up a winner before the indexers do.
The risks worth respecting are the same ones the industry has always faced. Launches still fail. Spectrum and regulatory approvals still slip. Competition between SpaceX, AST SpaceMobile, and EchoStar in direct-to-cell will produce winners and losers. The commercial revenue threshold is real, and these three funds give you three honest ways to own it.
Top Gaining Stocks
Top Losing Stocks